THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt as to any aspect of this circular or as to the action to be taken, you should consult your licensed securities dealer, bank manager, solicitor, professional accountant or other professional adviser. If you have sold or transferred all your shares in China State Construction International Holdings Limited, you should at once hand this circular and the accompanying form of proxy to the purchaser or the transferee or to the bank, licensed securities dealer or other agent through whom the sale or transfer was effected for transmission to the purchaser or the transferee.
Notes: Please insert the number of shares registered in your name(s). If no number is inserted, this form of proxy will be deemed to relate to all the shares in the capital of the Company registered in your name(s). Please insert full name(s) and address(es) in Block Capitals. If any proxy other than the Chairman of the Meeting is preferred, strike out the Words the Chairman of the Meeting or and then insert the name and address of the proxy desired in the space provided. A member may appoint one or more proxies to attend and vote in his stead. ANY ALTERATION MADE TO THIS FORM OF PROXY MUST BE DULY INITIALLED BY THE PERSON WHO SIGNS IT.
Dear Shareholders, On behalf of the board ( Board ) of directors ( Directors ) of Austar Lifesciences Limited ( Company ), I am pleased to present the annual report of the Company and its subsidiaries (collectively as the Group or AUSTAR ) for the year ended 31 December 2020 ( Year ). The year 2020 has been a challenging year for any individual, company and organization under the impact of the COVID-19 pandemic and its consequential policies. From a global perspective, the pandemic has not been slowing down even though China s pandemic conditions had become far stable and under extraordinary control. Under such conditions, the Group has been reacting, responding and acting during such extraordinary moments. Our colleagues could never have believed they were able to deliver our critical utilities and bioprocess systems to our COVID-19 vaccine manufacturer clients within 3 months from order to completion of installation and commissioning with construc
THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in doubt as to any aspect of this circular, you should consult your stockbroker or other registered dealer in securities, bank manager, solicitor, professional accountant or other professional adviser. If you have sold or transferred all your shares of Greenheart Group Limited, you should at once hand this circular and the accompanying form of proxy to the purchaser or the transferee or to the bank, stockbroker or other agent through whom the sale or the transfer was effected for transmission to the purchaser or the transferee. Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this circular, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of
the Hong Kong Special Administrative Region of the PRC 16 April 2021, being the latest practicable date prior to the printing of this circular for ascertaining certain information in this circular the Rules Governing the Listing of Securities on the Stock Exchange the People s Republic of China the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) the ordinary share(s) of HK$0.05 each in the share capital of the Company the registered holder(s) of the Share(s) The Stock Exchange of Hong Kong Limited the Codes on Takeovers and Mergers and Shares Repurchases issued by the Securities and Futures Commission in Hong Kong